The National Institute of Hematology and Blood Transfusion in Vietnam has been conducting a training program to teach autologous stem cell transplantation techniques to several hospitals across the country. This initiative is part of a larger project by the Ministry of Health, Project 1816, which aims to improve the quality of medical examination and treatment in lower-level hospitals.
In simple terms, autologous stem cell transplantation is a procedure where a patient’s own stem cells are collected, stored, and then returned (or “transplanted”) back into the patient to restore a type of tissue called hematopoietic tissue. This tissue is responsible for the formation of blood cells in our body.
This technique is particularly useful for treating both malignant (cancerous) and benign (non-cancerous) blood diseases. It offers patients a chance to recover and return to a normal life. However, it’s a complex procedure that requires strict adherence to certain steps to ensure the highest professional standards.
The training program, which runs from June 12 to August 4, involves medical personnel from several hospitals. Over eight weeks, these doctors and nurses receive both theoretical training and hands-on guidance on the autologous stem cell transplant procedure.
The National Institute of Hematology and Blood Transfusion has been a leader in this field, conducting autologous stem cell transplants since 2006. As of June 2023, they have successfully performed over 570 hematopoietic stem cell transplants using various complex techniques and cell sources. These sources include different types of stem cells, such as cord blood stem cells, and even half-matching transplants combined with cord blood stem cells.
The Institute is committed to providing support and transferring these advanced technologies to lower-level hospitals. This effort is aimed at improving the quality of diagnosis and treatment in various regions throughout the country, thereby enhancing access to better healthcare services for patients in their local communities. Thanks to the support and technology transfer provided by the Institute, several hospitals have successfully performed their first autologous stem cell transplants.
